Duncan NRI Faculty and Staff Publications

Language

English

Publication Date

9-23-2025

Journal

Cell Reports

DOI

10.1016/j.celrep.2025.116230

PMID

40914938

Abstract

Adenylosuccinate lyase deficiency (ADSLd) is a rare autosomal recessive purine metabolism disorder with several clinical manifestations. While toxic substrate accumulation is a known hallmark, no additional molecular mechanisms have been established. Here, we show that ADSLd is associated with mitochondrial dysfunction, including increased fragmentation, impaired respiration, and reduced ATP production. The severity of mitochondrial impairment correlates with ADSLd pathology, especially in mitochondria-dependent tissues. We also identify defects in mitochondrial dynamics and transport linked to ERK2 and AKT suppression. Notably, overexpressing constitutively active ERK2 or supplementing purine intermediates partially rescues the mitochondrial phenotype. These findings suggest an alternative disease mechanism and highlight mitochondrial metabolism as a potential therapeutic target in ADSLd.

Keywords

Proto-Oncogene Proteins c-akt, Humans, Mitochondria, Mitochondrial Diseases, Homeostasis, Mitogen-Activated Protein Kinase 1, Signal Transduction, Adenylosuccinate Lyase, Animals, Phenotype, Mice, Genetic Association Studies, ADSL, CP: Metabolism, ERK, mitochondria, purine metabolism, rare genetic disease

Published Open-Access

yes

fx1.jpg (29 kB)
Graphical Abstract

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.